Skip to content
Screener

Bio-Techne Corp. TECH Q4 2025 Annual earnings

Reported August 6, 2025 · Before market open

Revenue$317.0MBeat by $22.3M
EPS$0.53Beat by $0.03
Revenue estimate$294.6M
EPS estimate$0.50

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$292.4M
EPS estimate$0.46

Financials

Q4 2025

Income statement

See full
Revenue$317.0M+3.5%
Gross profit$198.8M-2.2%

Balance sheet

See full
Cash & equivalents$162.2M+6.8%
Total debt$444.1M+5.8%
Total equity$1.9B-7.3%
Total assets$2.6B-5.4%

Cash flow

See full
Operating cash flow$98.2M+30.1%
CapEx$4.9M-72.8%
Free cash flow$93.3M+62.2%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$7.84B-30.5%
Enterprise value$8.12B-29.6%
P/S6.4×-3.3×

Profitability

See full
Gross margin64.8%-1.6pp
FCF margin21%+0.7pp

Returns & leverage

See full
Debt / equity0.2×0.0×
Current ratio3.5×-0.4×

Segments

By product

See full
Consumables$252.9M+2.9%
Service$29.6M+5.1%
Instruments$28.9M+6.7%
Royalty$5.5M+9.0%

By geography

See full
US$176.4M—
CN$26.9M—
GB$14.8M—

By segment

See full
Protein Sciences$226.5M+5.8%
Diagnostics And Spatial Biology$89.7M-1.1%

FAQ

When did Bio-Techne Corp. report Q4 2025 earnings?
Bio-Techne Corp. (TECH) reported Q4 2025 earnings on August 6, 2025 before market open.
What were Bio-Techne Corp.'s Q4 2025 revenue and EPS?
Bio-Techne Corp. reported revenue of $317.0M and eps of $0.53 for Q4 2025.
Did Bio-Techne Corp. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $294.6M by $22.3M. EPS beat the consensus estimate of $0.50 by $0.03.
How did Bio-Techne Corp.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.5% from $306.1M a year earlier and eps grew 8.2% from $0.49.
Where can I find Bio-Techne Corp.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001558370-25-010393) and the 10-K periodic report (0001558370-25-011716) directly on SEC EDGAR. The filing index links above go to sec.gov.